期刊文献+

2型糖尿病患者外周血循环祖细胞的变化和临床意义 被引量:3

The Changes and Clinical Significance of Circulating Progenitor Cells in Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者外周血中循环祖细胞(CPCs,以CD34+细胞为分子标志物)的变化,并分析其与空腹血糖(FPG)、糖化血红蛋白(HbA1c)、超敏C反应蛋白(hsCRP)之间的相关性。方法采用流式细胞仪检测22例健康体检者(A组)、38例无并发症T2DM患者(B组)、32例T2DM合并微血管病变患者(C组)外周血CD34+细胞数量,同时检测3组外周血FPG、HbA1c和hsCRP水平。结果B、C组患者外周血CD34+细胞数量均降低,与A组相比,其CD34+、FPG、HbA1c、hsCRP水平差异均有统计学意义(均P<0.05)。外周血CD34+细胞数量与FPG、HbA1c、hsCRP均呈负相关。结论CPCs在一定程度上参与了T2DM及其微血管病变的发生、发展,可作为T2DM病情变化及其微血管病变的监测指标。 Objective To explore the changes of circulating progenitor cells (CPCs,characteristic of CD34^+) in peripheral blood and analyze the correlation between CPCs and fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), high sensitive C reactive protein (hsCRP) in type 2 diabetic patients (T2DM). Methods We detected peripheral blood CD34^+ cells by flow cytometry in 22 healthy volunteers (group A),38 T2DM without complications (group B) and 32 T2DM with micro-vascular disease (group C). Moreover, we also measured other parameters of peripheral blood,such as FPG, HbAlc,hsCRP. Results The CD34^+ from group B and group C were reduced. Compared with group A, there were significant differences in CD34^+ , FPG, HbAlc, hsCRP in group B and group C(all P〈0.05). An inverse correlation was found between CD34^+ and FPG,HbA1C,hsCRP. Conclusion The reduction of CPCs was associated with development of micro-vascular complication in T2DM. The number of CPCs is a predictor in the progress of T2DM and its micro-vascular complications.
作者 邹丛 刘建英
出处 《江西医学院学报》 CAS 2009年第7期62-64,共3页 Acta Academiae Medicinae Jiangxi
关键词 2型糖尿病 循环祖细胞 CD34+细胞 type 2 diabetes meilitus circulating progenitor cells CD34^+ cells
  • 相关文献

参考文献15

  • 1Fadini G P, Miorin M, Facco M, et al. Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus[J].J Am Coll Cardiol, 2005,45(9) : 1449-1457.
  • 2McClung J A,Naseer N,Saleem M,et al. Circulating Endothelial Cells Are Elevated in Patients with Type 2 Diabetes Mellitus Independently of HbAle [ J ]. Diabetologia, 2005, 48 ( 2 ) .. 345-350.
  • 3Fadini G P, De Kreutzenberg S V, Coracina A, et al. Circulating CD34^+ Cells, Metabolic Syndrome, and Cardiovascular Risk [J]. Eur Heart J,2006,27(18) :2247-2255.
  • 4Asai J,Takenaka H, Kusano K F, et al. Topical Sonic Hedgebog Gene Therapy Accelerates Wound Healing in Diabetes by Enhancing Endothelial Progenitor Cell-mediated Microvascular Remodeling[J]. Circulation, 2006,113 (20) : 2413-2424.
  • 5Heissig B, Hattori K, Dias S, et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP- 9 Mediated Release of Kit-ligand[J]. Cell, 2002,109 (5) : 625- 637.
  • 6Hink U, Li H, Mollnau H, et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus[J]. Cire Res, 2001, 88(2) :E14-E22.
  • 7Majka M, Janowska Wieczorek A, Ratajczak J, et al. Numerous Growth Factors, Cytokines, and Chemokines Are Secreted by Human CD34^+ Cells, Myeloblasts, Erythroblasts, and Megakaryoblasts and Regulate Normal Hematopoiesis in an Autocrine/Paraerine Manner[J]. Blood, 2001,97 (10) : 3075-3085.
  • 8朱禧星.炎症标志物可预测2型糖尿病发生?[J].国外医学(内分泌学分册),2003,23(3):164-165. 被引量:34
  • 9Ratnam S, Mookerjea S. The Regulation of Superoxide Generation and Nitric Oxide Synthesis by C-reactive Protein[J]. Immunology, 1998,94(4) : 560-568.
  • 10Ridker P M,Wilson P W,Grundy S M. Should C-reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?[J]. Circulation, 2004,109 (23) : 2818-2825.

共引文献33

同被引文献37

引证文献3

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部